Why is the news that CVS Caremark has secured the mail-order and specialty prescription drug benefit for Federal Employee Program so important? Well, some pundits might say there is no indication that the integrated retail-pharmacy benefit manager model had anything to do with why FEP chose Caremark over Medco. It doesn't matter. As any football coach would say, "A win's a win," and this is a big one.
To celebrate Men's Health Month, Sam's Club is offering free men's health screening tests this weekend at select stores, which will be sponsored by Unilever brands, including Dove Men's deodorant and body wash.
Capital spending for the retail industry is expected to increase 16% in 2011 to $42.5 billion, with all subsegments projecting double-digit percentage increases — except for mass merchants, whose growth is projected to rise 9% — according to a survey by Equity Research.
In a major win for its pharmacy benefit management business, CVS Caremark will handle the $3 billion mail-order and specialty prescription drug benefit for the Federal Employee Program starting January 2012, which, for the last three years, had been handled by rival Medco Health Solutions.
CVS Caremark and a panel of health experts explored research findings and the problem of medication nonadherence Thursday morning during CVS Caremark’s first-ever national forum on medication nonadherence at the National Press Club in Washington, D.C.
The fact that CVS Caremark convened its first-ever national forum in an effort to battle the $300 billion problem of medication nonadherence is important on several fronts, including the simple fact that retail pharmacy deserves credit for more effectively communicating what adherence is and why it's important.
Medication nonadherence is sort of similar to substance abuse: It’s a societal issue that stems from multiple causes and as such, probably will never completely disappear; however, it still can be mitigated. And because it stems from multiple causes, effectively combating it also requires multiple strategies.
If beauty is in the eye of the beholder, then there are plenty of folks beholding Walgreens and its New York palette, Duane Reade. So it should come as no surprise that Walgreens is positioning its heavy hitters against the beauty category, given the number of recent changes Walgreens has made across its beauty facing.
Walgreens on Wednesday promoted Mike Spear to divisional merchandise manager of the retailer’s personal care division and announced that Lauren Vondrasek is transitioning to the company’s beauty merchandising unit, which is headed by Barbara Larson.
The Louisiana State Senate has given the green light to legislation that would expand pharmacy's ability to administer immunizations, and now the House of Representatives is slated to vote on the legislation in the coming days. The passage of SB 60 is important because expanding the pharmacist's ability to administer vaccinations is a relatively low-cost way to expand access and ultimately improve outcomes.
It’s often said that yesterday’s science fiction is tomorrow’s reality, and while automakers have yet to unveil flying cars similar to the ones in “Blade Runner,” the integration of WellDoc’s services with Ford Motor’s SYNC technology serves as a prime example.
To say that the impact of high prices at the pump this year is not as bad as it was in 2008 may be a testament to just how bad it was in 2008. As long as the price-per-gallon hovers above or below that magical $4, it’s still plenty bad, and there still are plenty of people who are changing shopping behaviors because of it.
Ford Motor on Wednesday announced its research partnership with WellDoc — a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs — around integrating WellDoc services into Ford vehicles through the automaker’s SYNC voice-activated in-car connectivity system.
The Generic Pharmaceutical Association and other trade and patient advocacy groups can push generic drug usage as a way to save on medical costs, but throwing the weight of Congress behind generics gives them a bigger boost than ever.
Life doesn’t give you too many of those Magic 8 Ball moments, at least not the kind you can find at the pharmacy counter. Just ask the 8 Ball if medicine compliance is important for retail pharmacy, and the answer undoubtedly will come back, “It is decidedly so.”
As reported, CVS Caremark's annual meeting of stockholders was of special importance as it marked the beginning of a new chapter for both CVS Caremark and its former chairman and CEO Tom Ryan, who officially retired from the company after more than 30 years of service.
CVS Caremark’s annual meeting of stockholders held Wednesday morning was an emotional and momentous occasion for the company as it marked the official retirement of Tom Ryan, former chairman and CEO, and the beginning of a new chapter as Larry Merlo takes the reigns as CEO.
With all the talk among the investment community and press about what CVS Caremark should do with its PBM business, it really comes as little surprise that president and CEO Larry Merlo hit the topic head on during Thursday's first-quarter conference call — insisting that there are no plans to split the company.
CVS Caremark is “off to a good start” in 2011 as first-quarter results registered slightly above guidance for both the retail and PBM businesses, and the retail segment continues to gain share. But what president and CEO Larry Merlo wanted to clarify straight away during Thursday morning’s conference was the company’s commitment to its PBM division, and he outlined its plan to further improve PBM performance.